Sign up for our FREE GI E-Weekly for more coverage like this sent to your inbox!
Cologuard is designed to detect DNA taken from a stool sample that indicates the presence of colorectal cancer or pre-cancerous polyps.
The results, determined during a DeeP-C clinical study, will be submitted to the FDA as part of the test’s pre-market approval process.
More Articles on Gastroenterology:
20 Statistics on Gastroenterologist Burnout
3 Statistics on Colonoscopy Procedure Times in ASCs
EndoSoft to Present GI Software at Digestive Disease Week in Orlando
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
